BCR-ABL %IS Kit Monitors CML Treatment Response
In a study of reproducibility, the kit showed negligible contributions to variance from day, operator, site, or kit lot.
Read MorePosted by Steve Halasey | Feb 26, 2020 | Molecular Diagnostics |
In a study of reproducibility, the kit showed negligible contributions to variance from day, operator, site, or kit lot.
Read MorePosted by | Jan 9, 2020 | Leukemia |
Sight Diagnostics’ patented Olo analyzer digitizes blood into images to perform the most common blood test in minutes, using just two drops of blood.
Read MorePosted by | Dec 31, 2019 | Cardiovascular, Leukemia |
The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read MorePosted by Steve Halasey | Nov 6, 2019 | Breast, Lymphoma |
A novel PD-L1 assay advances the promise of precision medicine.
Read MorePosted by Steve Halasey | Oct 8, 2019 | Culture Media, Cytology, Histology, Leukemia, Lymphoma, Microscopy, Slides, Software |
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read More